Sign Up Today and Learn More About Elion Therapeutics Stock
Invest in or calculate the value of your shares in Elion Therapeutics or other pre-IPO companies through EquityZen's platform.
Elion Therapeutics Stock (ELTH)
Elion Therapeutics is a cutting-edge biotechnology business focused on treating life-threatening IFIs
About Elion Therapeutics Stock
Founded
1955
Headquarters
Boston, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Elion Therapeutics Press Mentions
Stay in the know about the latest news on Elion Therapeutics
Elion Therapeutics: $81 Million Closed To Transform Treatment Of Life-Threatening Invasive Fungal Infections
pulse2 • Jul 24, 2024
Elion Therapeutics raises funds to develop antifungal medication
crainsnewyork • Jun 24, 2024
Elion Therapeutics Closes $81 Million Series B Funding Round Led by Deerfield Management and AMR Action Fund
prnewswire • Jun 24, 2024
Antifungal specialist raises $81 million in series B round
thepharmaletter • Jun 24, 2024
Elion Therapeutics Closes $81M Series B Funding Round
finsmes • Jun 24, 2024
Elion Therapeutics Management
Leadership team at Elion Therapeutics
Founder
Marty Burke
Join now and verify your accreditation status to gain access to:
- Elion Therapeutics current valuation
- Elion Therapeutics stock price
- Available deals in Elion Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Elion Therapeutics Stock
How to invest in Elion Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Elion Therapeutics through EquityZen funds. These investments are made available by existing Elion Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Elion Therapeutics stock?
Shareholders can sell their Elion Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
